Epsilon Healthcare Limited (HDRPF)
OTHER OTC:HDRPF
Want to see HDRPF full AI Analyst Report?
HDRPF Stock Chart & Stats
$0.01
>-$0.01(0.00%)
At close: 4:00 PM EST
$0.01
>-$0.01(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume8.00K
Average Volume (3M)N/A
Market Cap
$5.63M
Enterprise Value$21.31M
Total Cash (Recent Filing)$242.86K
Total Debt (Recent Filing)$14.16M
Price to Earnings (P/E)4.0
Beta-0.01
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding389,104,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)4.19
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market Cap3.79
Enterprise Value/Revenue2.27
Enterprise Value/Gross Profit10.18
Enterprise Value/Ebitda-10.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manufacturing CapabilitycGMP-compliant manufacturing is a durable competitive asset in pharma markets. It enables supply to regulated healthcare customers, supports quality-driven contracts and private-label production, creates higher barriers to entry and underpins stable long-term revenue opportunities.
Revenue ReboundA ~53% revenue rebound signals renewed market traction and improving product demand. Sustained top-line growth can enable better fixed-cost absorption and drive margin recovery over months, improving prospects for scalable profitability if the company maintains this trend.
Diversified Revenue StreamsPrivate-label manufacturing and distributor/healthcare partnerships diversify income sources and reduce single-customer concentration. Long-term contracts and B2B relationships help stabilize revenue, improve capacity utilization and support gradual margin improvement as scale increases.
Bears Say
Persistent LossesMeaningfully negative net margins (~-22%) indicate the company has not yet converted revenue growth into sustainable profits. Continued losses erode equity, limit reinvestment capacity and increase reliance on external financing, creating a structural hurdle to long-term financial health.
Weak Cash GenerationConsistently negative OCF and FCF mean the business consumes cash to operate, forcing dependence on external funding or balance sheet support. Over several months, weak cash generation makes it harder to invest, meet obligations and withstand revenue volatility without diluting shareholders or raising debt.
High LeverageA sharp rise to ~4.7x debt/equity materially increases financial risk. High leverage raises interest and refinancing pressures, reduces flexibility to fund growth, and magnifies solvency risk given continued losses and weak cash flow, threatening long-term operational resilience.
Epsilon Healthcare Limited News
HDRPF FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is $5.63M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 112 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported $0.001 earnings per share for the quarter, beating the consensus estimate of N/A by $0.001.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of $0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in HDRPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
404.65%
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Ownership Overview
Options Prices
Currently, No data available
---